Press "Enter" to skip to content

US biopharma AbbVie to buy Botox maker Allergan for $63 billion

US biopharmaceutical company AbbVie said Tuesday it would buy Botox-maker Allergan for about $63 billion, moving to diversify its product line as the industry faces pressure on drug prices.

Original source: https://health.economictimes.indiatimes.com/news/pharma/us-biopharma-abbvie-to-buy-botox-maker-allergan-for-63-billion/69951560?utm_source=RSS&utm_medium=ETRSS

Also Read:   Doctor faces probe for prescribing condoms for stomach pain